Related Experiment Video
Updated: Jul 9, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease
Nicoletta Masera1, Luisa Tavecchia, Lorena Pozzi
1Clinica Pediatrica, Università di Milano-Bicocca, Ospedale San Gerardo, Via Pergolesi 33, Monza 20052, Italy. nicoletta.masera@hsgerardo.org
Insights
Exchange transfusion programs offer effective sickle cell disease management in children, improving quality of life without significant complications. Costs are comparable to chronic transfusion, making it a viable alternative for severe cases.
Area of Science:
- Hematology
- Pediatrics
- Transfusion Medicine
Background:
- Sickle cell disease (SCD) is a genetic blood disorder requiring effective management strategies.
- Exchange transfusion is a therapeutic option for SCD complications.
- Evaluating its long-term efficacy, safety, and cost is crucial.
Purpose of the Study:
- To assess the efficacy, safety, and cost-effectiveness of exchange transfusion programs in pediatric sickle cell patients.
- To compare periodic erythroexchange with chronic transfusion regimens.
- To identify its role in managing severe SCD cases.
Main Methods:
- Retrospective study over 11 years.
- Inclusion of 34 pediatric sickle cell patients.
- Focus on 13 high-risk patients undergoing periodic erythroexchange.
Main Results:
- Good clinical control and improved quality of life observed.
- No disease-related complications or significant iron overload reported.
- Procedure-related side effects were absent, and costs were comparable to chronic transfusion.
Conclusions:
- Periodic erythroexchange is a safe and effective treatment for severe sickle cell disease in children.
- It offers a good alternative to chronic transfusion, especially for hydroxyurea-intolerant or non-responsive patients.
- This program improves patient outcomes and quality of life.
Abstract:
We performed an 11 year retrospective study on 34 sickle-cell paediatric patients, focusing on efficacy, safety and costs of an exchange transfusion program in 13 high risk patients. A good clinical control with improvement in patients' quality of life, no disease related complications, no significant iron overload and no procedure related side effects were observed during periodic erythroexchange. Costs of periodic erythroexchange versus chronic transfusion regimen were comparable. Periodic erythroexchange appeared a good alternative to chronic transfusion regimen for controlling the most severe forms of disease, particularly in patients who do not tolerate or do not respond to hydroxyurea.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Erythropoiesis
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
